The effect of ferrous sulphate on the treatment of symptoms in children with attention deficit hyperactivity disorder
- Conditions
- Attention deficit hyperactivity disorder.Attention-deficit hyperactivity disorder, combined type
- Registration Number
- IRCT20120314009297N3
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 38
7-14 years old children
Diagnosed attention deficit hyperactivity disorder children by two psychiatrists and based on DSM-V and without iron deficiency and anemia (Serum ferritin above 15 µg /L and serum hemoglobin equal to or greater than 11 g /dl )
All patients are on standard treatment regimen for attention-deficit hyperactivity disorder for at least 3 months and a stable dose for at least 1 month.
Acute phase of the disease
Psychiatric comorbidity as defined by DSM-V (bipolar disorder, Major depressive disorder)
Mental retardation
Neurological diseases such as delirium, seizure, traumatic brain injury
Current significant unstable medical illness (such as unstable cardiac disease, hepatic or renal impairment, evidence or history of malignancy or any significant hematological, endocrine)/ HIV infection / abnormalities on physical examination, vital signs, electrocardiogram (ECG), or clinical laboratory values
Hypersensitivity to iron sulphate
Previous treatment with any enriched medical products with iron at least 2 months before the initiation
Unwillingness of the patient or his guardian to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method